SubHero Banner

Ragwitek® (short ragweed pollen allergen extract) – Expanded indication

April 19, 2021 - ALK-Abelló announced the FDA approval of Ragwitek (short ragweed pollen allergen extract), for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen. Ragwitek is approved for use in persons 5 through 65 years of age.

Download PDF